Ophthalmologist and Optometrist Glaucoma Prescribing Patterns Based on 2015 Medicare Part D Data
| Autor: | Aaron Z. Priluck, Jamie Dietze |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
Optometrists
genetic structures Medicare Part D Glaucoma Drug Prescriptions 01 natural sciences 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine Generic drug medicine Drugs Generic Humans Practice Patterns Physicians' 0101 mathematics Latanoprost Antihypertensive Agents Ophthalmologists Bimatoprost business.industry Brimonidine 010102 general mathematics General Medicine medicine.disease United States eye diseases Cross-Sectional Studies Drug class chemistry 030221 ophthalmology & optometry Optometry Travoprost business medicine.drug |
| Zdroj: | Ophthalmology Glaucoma. 2:63-66 |
| ISSN: | 2589-4196 |
| Popis: | Purpose To determine differences in prescribing patterns of glaucoma drugs between ophthalmologists and optometrists in terms of (1) the proportions of generics prescribed when brand-name drugs were also available, (2) the relative proportions of drugs prescribed within a drug class, and (3) the relative frequency of all glaucoma drugs prescribed. Design Cross-sectional study. Participants All ophthalmologists and optometrists in the United States who prescribed any of the 36 drugs studied through Medicare Part D in 2015. Methods Outcome measures were calculated using Excel 2016 (Microsoft, Redmond, WA) based on the 2015 Medicare Part D Prescriber data. The total number of drug claims for 36 glaucoma drugs by all ophthalmologists and optometrists through Medicare Part D in 2015 was determined. These data were then used to calculate, for each drug class, the relative proportions of each drug prescribed by ophthalmologists and optometrists in addition to the proportion of claims that were for the generic drug when at least 1 brand-name alternative was available for both professions. Results The difference between ophthalmologists’ and optometrists’ proportions of claims that were for generics when at least 1 brand-name drug was available was generally less than 1%, with both professions’ patients receiving primarily generic drugs. However, patients of both ophthalmologists and optometrists use relatively low proportions of generic betaxolol, brimonidine, travoprost, and bimatoprost (approximately 46%, 58%, 1%, and 0% of claims were for these generics, respectively, when compared with brand-name drugs for both ophthalmologists and optometrists). Within each drug class, ophthalmologists and optometrists generally chose the same drug. Overall, ophthalmologists prescribed a wider range of drugs, but both ophthalmologists and optometrists prescribed latanoprost most often. Conclusions Ophthalmologists and optometrists exhibit similar clinical judgement when choosing a particular drug within a drug class. However, ophthalmologists tend to prescribe more drugs from a wider range of drug classes. Both ophthalmologists and optometrists could prescribe more generic betaxolol, brimonidine, travoprost, and bimatoprost, though generic bimatoprost only became available in 2015. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|